GRADALIS, INC. — Form D
GRADALIS, INC. of Carrollton, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-12. The offering totals $30.0M, of which $12.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-12
- Form: D
- Accession: 0001457915-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $12.7M
- Remaining: $17.3M
- Minimum investment: $250K
- Investors: 24
- Date of first sale: 2025-06-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-548754
Issuer
- Name: GRADALIS, INC.
- CIK: 0001457915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2545 Golden Bear Drive, Carrollton, TX, 75006
- Phone: (214) 442-8100
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Joseph F Berry | Director | — |
| Joe C Cunningham | Director | Dallas, TX |
| Harry R Jacobson | Director | Nashville, TN |
| Robert P Landin | Director | College Station, TX |
| John P Nemunaitis | Director | Dallas, TX |
| Scott C Seaman | Director | Dallas, TX |
| David M Shanahan | Director | Dallas, TX |
| Mark C Early | Executive Officer | Dallas, TX |
| John P Nemunaitis | Executive Officer | Dallas, TX |
| David M Shanahan | Executive Officer | Dallas, TX |
| ROBERT LANDIN | Director | DALLAS, TX |
| Scott Seaman | Director | Greenwich, CT |
| David Shanahan | Director | College Station, TX |
| David Shanahan | Executive Officer | College Station, TX |
| Ernest Bognar | Executive Officer | Dallas, TX |
| Gladice Wallraven | Executive Officer | Dallas, TX |
| Joe Cunningham, M.D. | Director | Dallas, TX |
| Harry Jacobson, M.D. | Director | Dallas, TX |
| Thomas Lyles | Director | Dallas, TX |
| John Nemunaitis, M.D. | Director | Dallas, TX |
| John Nemunaitis, M.D. | Executive Officer | Dallas, TX |
| Renee Larson | Executive Officer | Dallas, TX |
Other filings by this issuer (1)
More